Adamantane Derivatives Of Aza-Crown Ethers And Their Use In Treatment Of Tumor
AssigneeRudjer Boskovic Institute
InventorsMarijeta Kralj, Kata Majerski, Tatjana Sumanovac Ramljak, Marko Marjanovic
Life of this patent
Estimating the term…
Loading patent…
AssigneeRudjer Boskovic Institute
InventorsMarijeta Kralj, Kata Majerski, Tatjana Sumanovac Ramljak, Marko Marjanovic
Estimating the term…
The invention relates to adamantane diaza-crown ether derivatives and the use of mono and diaza-crown ether adamantine derivatives in treatment, especially in tumor treatment. Adamantane aza-crown ethers were obtained by reaction of the corresponding adamantane derived tosylates or adamantane acid chlorides with mono- and diaza-18-crown-6. The prepared compounds showed moderate (monoaza-18-crown-6) to strong (diaza-18-crown-6) antiproliferative and cytotoxic activity on several tumor cell lines, revealing their potential for inhibiting the growth of other tumor cells.
A compound having general formula I:
A compound having general formula II
A pharmaceutical composition for treatment of cancer and tumors, comprising:
A pharmaceutical composition for treatment of cancer and tumors, comprising:
Use of a compound having general formula I:
Use of a compound having general formula II
Dependencies are inferred from the claim text.